367 related articles for article (PubMed ID: 1553573)
21. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line.
Takauji R; Tohyama K; Ueda T; Nakamura T
Jpn J Cancer Res; 1993 Apr; 84(4):445-50. PubMed ID: 7685751
[TBL] [Abstract][Full Text] [Related]
23. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
[TBL] [Abstract][Full Text] [Related]
24. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine.
Braess J; Wegendt C; Jahns-Streubel G; Kern W; Keye S; Unterhalt M; Schleyer E; Hiddemann W
Br J Haematol; 2000 May; 109(2):388-95. PubMed ID: 10848830
[TBL] [Abstract][Full Text] [Related]
25. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
Andreeff M; Tafuri A; Hegewisch-Becker S
Haematol Blood Transfus; 1990; 33():747-62. PubMed ID: 2323674
[TBL] [Abstract][Full Text] [Related]
26. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
[TBL] [Abstract][Full Text] [Related]
27. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
[TBL] [Abstract][Full Text] [Related]
28. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
[TBL] [Abstract][Full Text] [Related]
29. Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Hiddemann W; Zühlsdorf M; Wörmann B; Koenigsmann M; Büchner T
Leuk Res; 1990; 14(4):347-52. PubMed ID: 2185381
[TBL] [Abstract][Full Text] [Related]
30. Myelosuppressive effects of cytosine arabinoside (Ara-C) on growth factor-dependent human long-term bone marrow cultures (LTBMC).
Kalla P; Oster W; Seiler FR; Rüde E; Krumwieh D
Int J Cell Cloning; 1992 Jan; 10(1):54-62. PubMed ID: 1552225
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
Waga K; Furusawa S; Nagashima S; Saito K; Shishido H
Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
[TBL] [Abstract][Full Text] [Related]
32. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
33. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
[TBL] [Abstract][Full Text] [Related]
34. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Safah H; Graham G
Exp Hematol; 1991 Aug; 19(7):669-73. PubMed ID: 1893953
[TBL] [Abstract][Full Text] [Related]
36. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.
Bhalla K; Tang C; Ibrado AM; Grant S; Tourkina E; Holladay C; Hughes M; Mahoney ME; Huang Y
Blood; 1992 Dec; 80(11):2883-90. PubMed ID: 1450413
[TBL] [Abstract][Full Text] [Related]
39. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
[TBL] [Abstract][Full Text] [Related]
40. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
